HistoIndex Launches FibroSIGHT™ Plus for AI Fibrosis Analysis
HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT Plus, its second Laboratory Developed Test (LDT) available in the United States. Building on the foundation of FibroSIGHT[1], which debuted just months earlier, FibroSIGHT Plus introduces an additional feature of automated quantitative analysis of fibrosis – a key advancement that enables…
